Cargando…
Drugs for COVID-19 Treatment: A New Challenge
COVID-19 infection is a new disease and our knowledge is limited; day in and day out more and more interesting yet diverse observations are reported by the different research groups from different corners of the world. So, there is an urgent requirement of the invention of some effective and efficie...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037400/ https://www.ncbi.nlm.nih.gov/pubmed/36961509 http://dx.doi.org/10.1007/s12010-023-04439-4 |
_version_ | 1784911871014338560 |
---|---|
author | Talukder, Pratik Saha, Arunima Roy, Sohini Ghosh, Gargi Roy, Debshikha Dutta Barua, Snejuti |
author_facet | Talukder, Pratik Saha, Arunima Roy, Sohini Ghosh, Gargi Roy, Debshikha Dutta Barua, Snejuti |
author_sort | Talukder, Pratik |
collection | PubMed |
description | COVID-19 infection is a new disease and our knowledge is limited; day in and day out more and more interesting yet diverse observations are reported by the different research groups from different corners of the world. So, there is an urgent requirement of the invention of some effective and efficient drugs that can carry out the end of the deadly viral infection. Throughout the world, there have been many efforts carried out in different labs to invent such a drug and also identifying any pre-existing drugs which can carry out the killing of the virus. In this review, an effort has been made to understand the potential drugs which can be used against the SARS-CoV-2 viral infection. Again, the strategies on the current and the future drug discovery mechanisms against the SARS-CoV-2 are also mentioned. The different drugs made and the drugs re-used and also the drugs which are in the making process in different research laboratories across the world are also mentioned. To combat this unexpected crisis, we still need some more efforts from the different scientific communities around the world for finding a cure against this viral infection and this is needed to be done for the prevention of more loss of human life. |
format | Online Article Text |
id | pubmed-10037400 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-100374002023-03-24 Drugs for COVID-19 Treatment: A New Challenge Talukder, Pratik Saha, Arunima Roy, Sohini Ghosh, Gargi Roy, Debshikha Dutta Barua, Snejuti Appl Biochem Biotechnol Review Article COVID-19 infection is a new disease and our knowledge is limited; day in and day out more and more interesting yet diverse observations are reported by the different research groups from different corners of the world. So, there is an urgent requirement of the invention of some effective and efficient drugs that can carry out the end of the deadly viral infection. Throughout the world, there have been many efforts carried out in different labs to invent such a drug and also identifying any pre-existing drugs which can carry out the killing of the virus. In this review, an effort has been made to understand the potential drugs which can be used against the SARS-CoV-2 viral infection. Again, the strategies on the current and the future drug discovery mechanisms against the SARS-CoV-2 are also mentioned. The different drugs made and the drugs re-used and also the drugs which are in the making process in different research laboratories across the world are also mentioned. To combat this unexpected crisis, we still need some more efforts from the different scientific communities around the world for finding a cure against this viral infection and this is needed to be done for the prevention of more loss of human life. Springer US 2023-03-24 2023 /pmc/articles/PMC10037400/ /pubmed/36961509 http://dx.doi.org/10.1007/s12010-023-04439-4 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Review Article Talukder, Pratik Saha, Arunima Roy, Sohini Ghosh, Gargi Roy, Debshikha Dutta Barua, Snejuti Drugs for COVID-19 Treatment: A New Challenge |
title | Drugs for COVID-19 Treatment: A New Challenge |
title_full | Drugs for COVID-19 Treatment: A New Challenge |
title_fullStr | Drugs for COVID-19 Treatment: A New Challenge |
title_full_unstemmed | Drugs for COVID-19 Treatment: A New Challenge |
title_short | Drugs for COVID-19 Treatment: A New Challenge |
title_sort | drugs for covid-19 treatment: a new challenge |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037400/ https://www.ncbi.nlm.nih.gov/pubmed/36961509 http://dx.doi.org/10.1007/s12010-023-04439-4 |
work_keys_str_mv | AT talukderpratik drugsforcovid19treatmentanewchallenge AT sahaarunima drugsforcovid19treatmentanewchallenge AT roysohini drugsforcovid19treatmentanewchallenge AT ghoshgargi drugsforcovid19treatmentanewchallenge AT roydebshikhadutta drugsforcovid19treatmentanewchallenge AT baruasnejuti drugsforcovid19treatmentanewchallenge |